Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

603235.SS

SELLREMOVE

JiangXi Tianxin Pharmaceutical Co., Ltd. · Consumer Defensive · China · $1.5B · Avg Vol: $1M/d

32
StockRank
Q
57
V
28
M
37
P/E (TTM)
19.8x
ROE
10.5%
D/E
0.1x
Dividend %
2.3%
AI CONVICTION THESIS

JiangXi Tianxin is primarily a manufacturer of vitamins and APIs. It operates as a commodity cyclical with low pricing power and high input cost sensitivity, making it unsuitable for our concentrated portfolio.

COMPANY DESCRIPTION

JiangXi Tianxin Pharmaceutical Co., Ltd. specializes in the R&D, production, and sale of vitamins, including Vitamin B6, Vitamin B1, and Folic Acid, for food, feed, and pharmaceutical applications. The company is a major global supplier in the vitamin industry, maintaining a significant market share through large-scale, cost-efficient production. Its competitive advantage is driven by proprietary synthesis technologies, strict quality certifications, and strong relationships with global feed and food conglomerates.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGR
Revenue340.6M278.1M326.4M346.5M0.6%
EPS0.220.160.220.20-3.7%
Shares437.8M437.8M437.8M437.8M0.0%
Debt1.2M16.0M22.0M59.8M268.9%
Equity599.7M625.5M682.1M726.5M6.6%
Op CF89.6M107.8M73.8M93.0M1.2%
Inv CF-67.3M-44.8M-227.7M-13.2M
Fin CF171.8M-31.9M-35.5M-5.8M
Loading...
PRICE (1Y)-10.1%
3.373.483.593.703.81May 12Jun 2Jun 23
SMA 50SMA 200
Close
$3.42
RSI (14)
34.3
52W High
$4.44
From 52W High
0.8%

SCORE BREAKDOWN

Quality
57
ROIC
12.7%63.3
ROE
10.5%52.7
GP/Assets
15.0%20.2
Op. Margin
29.0%94.3
FCF/Assets
1.2%31.4
Piotroski
525.3
Int. Cover
50.0x85.9
D/E Ratio
0.07x81.0
Current Ratio
5.08x94.1
Value
28
P/E (TTM)
19.8x37.8
EV/EBITDA
11.8x35.4
P/FCF
927.6x3.5
P/B
2.0x40.2
P/S
4.4x8.0
Div Yield
2.3%37.9
Momentum
37
52W High %
77%46.5
RS 6M
-25%49.2
SMA 50/200
0.94x32.6
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
N/A
Q Growth
-33%15.4

FUNDAMENTALS

Market Cap
$1.5B
P/E (Forward)
Gross Margin
39.0%

SECTOR PEERS

Closest peers in Consumer Defensive, ranked by industry match, size, and score similarity. Cross-listings of 603235.SS are excluded.

TickerCompanyMkt CapStockRankSignal
603235.SSJiangXi Tianxin Pharmaceutical Co., Ltd.(you)$1.5B32SELL
603027.SSQianhe Condiment and Food Co., Ltd.$1.5B28SELL
600597.SSBright Dairy & Food Co.,Ltd$1.3B27SELL
600251.SSXinjiang Guannong Co.,Ltd.$1.1B36HOLD
002100.SZTECON BIOLOGY Co.LTD$1.2B24SELL
600305.SSJiangsu Hengshun Vinegar-Industry Co.,Ltd$1.1B26SELL
002847.SZYanKer shop Food Co.,Ltd$1.9B38HOLD
001313.SZGuangdong Yuehai Feeds Group Co.,Ltd.$782M30SELL
603711.SSXIANGPIAOPIAO Food Co.,Ltd$743M35SELL
002626.SZXiamen Kingdomway Group Company$1.3B17STRONG SELL

Peer medians: ROE 8.4% · P/E 21.7x · Gross margin 33.2%

JiangXi Tianxin Pharmaceutical Co., Ltd. (603235.SS) — Stock Score Summary

JiangXi Tianxin Pharmaceutical Co., Ltd. (603235.SS) has a MoatMap StockRank of 32/100 based on Quality (57/100), Value (28/100), and Momentum (37/100) factor scores. The current signal is SELL. JiangXi Tianxin is primarily a manufacturer of vitamins and APIs. It operates as a commodity cyclical with low pricing power and high input cost sensitivity, making it unsuitable for our concentrated portfolio.

JiangXi Tianxin Pharmaceutical Co., Ltd. specializes in the R&D, production, and sale of vitamins, including Vitamin B6, Vitamin B1, and Folic Acid, for food, feed, and pharmaceutical applications. The company is a major global supplier in the vitamin industry, maintaining a significant market share through large-scale, cost-efficient production. Its competitive advantage is driven by proprietary synthesis technologies, strict quality certifications, and strong relationships with global feed and food conglomerates.

Key Financial Metrics

Price$3.42
Market Cap$1.5B
P/E (TTM)19.83
Price/Book2.02
Return on Equity10.5%
Return on Invested Capital12.7%
Debt/Equity6.86
Gross Margin39.0%
Operating Margin29.0%
Revenue Growth3.4%
Dividend Yield2.3%
Free Cash Flow$2M

JiangXi Tianxin Pharmaceutical Co., Ltd. operates in the Packaged Foods industry, part of the Consumer Defensive sector (China).

Frequently Asked Questions

What is JiangXi Tianxin Pharmaceutical Co., Ltd.’s (603235.SS) StockRank?
MoatMap’s StockRank for JiangXi Tianxin Pharmaceutical Co., Ltd. (603235.SS) is 32/100, with a Sell signal. It is a composite of Quality (57), Value (28), and Momentum (37) factor ranks across MoatMap’s 20,000+ stock universe.
Does JiangXi Tianxin Pharmaceutical Co., Ltd. have an economic moat?
JiangXi Tianxin Pharmaceutical Co., Ltd. (603235.SS) has a Quality factor score of 57/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is JiangXi Tianxin Pharmaceutical Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for JiangXi Tianxin Pharmaceutical Co., Ltd. (603235.SS) is Sell, based on a StockRank of 32/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is JiangXi Tianxin Pharmaceutical Co., Ltd. in?
JiangXi Tianxin Pharmaceutical Co., Ltd. (603235.SS) operates in the Consumer Defensive sector, specifically the Packaged Foods industry (China).